Voriconazole versus isavuconazole for invasive aspergillosis: a retrospective analysis in a medically insured U.S. population (2017–2020)

Voriconazole versus isavuconazole for invasive aspergillosis: a retrospective analysis in a medically insured U.S. population (2017–2020)

Background: While isavuconazole (ISA) has demonstrated non-inferiority to voriconazole (VCZ) for invasive aspergillosis (IA) in clinical trials, real-world comparisons are limited. Objectives: To compare treatment completion, adverse events, hospitalizations, and healthcare costs in patients treated...

Full description

Saved in:
Bibliographic Details
Main Authors: Sophea Chan, Laura Leigh Stoudenmire, Xianyan Chen, Duna Zhan, Andrés F. Henao-Martínez, Daniel B. Chastain
Format: Article
Language:English
Published: SAGE Publishing 2025-06-01
Series:Therapeutic Advances in Infectious Disease
Online Access:https://doi.org/10.1177/20499361251347778
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items